Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter

8 Aug 2022 , 02:55 PM

Net profit of Astrazeneca Pharma India rose 96.78% to Rs 20.15 crore in the quarter ended June 2022 as against Rs 10.24 crore during the previous quarter ended June 2021. Sales rose 32.46% to Rs 232.33 crore in the quarter ended June 2022 as against Rs 175.40 crore during the previous quarter ended June 2021.

Particulars	Quarter Ended
?	Jun. 2022	Jun. 2021	% Var.
Sales	232.33	175.40	32
OPM %	12.04	8.91	–
PBDT	31.89	18.26	75
PBT	27.30	13.50	102
NP	20.15	10.24	97

Powered by Capital Market – Live News